3,916 Shares in Lam Research Corporation $LRCX Bought by Income Insurance Ltd

Income Insurance Ltd purchased a new position in Lam Research Corporation (NASDAQ:LRCX) in the fourth quarter, HoldingsChannel reports. The fund purchased 3,916 shares of the semiconductor company’s stock, valued at approximately $670,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Vanguard Group Inc. increased its stake in shares of Lam Research by 0.3% in the third quarter. Vanguard Group Inc. now owns 130,974,214 shares of the semiconductor company’s stock worth $17,537,447,000 after buying an additional 364,949 shares during the last quarter. State Street Corp increased its stake in shares of Lam Research by 0.4% in the third quarter. State Street Corp now owns 59,817,352 shares of the semiconductor company’s stock worth $8,024,684,000 after buying an additional 265,805 shares during the last quarter. Invesco Ltd. increased its stake in shares of Lam Research by 18.2% in the third quarter. Invesco Ltd. now owns 21,182,948 shares of the semiconductor company’s stock worth $2,836,397,000 after buying an additional 3,263,658 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its stake in shares of Lam Research by 781.3% in the third quarter. Arrowstreet Capital Limited Partnership now owns 11,340,865 shares of the semiconductor company’s stock worth $1,518,542,000 after buying an additional 10,053,978 shares during the last quarter. Finally, Nordea Investment Management AB increased its stake in shares of Lam Research by 6.8% in the third quarter. Nordea Investment Management AB now owns 11,312,752 shares of the semiconductor company’s stock worth $1,512,854,000 after buying an additional 718,178 shares during the last quarter. Institutional investors own 84.61% of the company’s stock.

Insider Activity

In other news, CFO Douglas R. Bettinger sold 50,057 shares of the business’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the completion of the transaction, the chief financial officer owned 1,081,705 shares of the company’s stock, valued at approximately $242,334,371.15. The trade was a 4.42% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Neil J. Fernandes sold 18,170 shares of the business’s stock in a transaction on Friday, May 1st. The shares were sold at an average price of $255.14, for a total transaction of $4,635,893.80. Following the transaction, the senior vice president directly owned 66,129 shares of the company’s stock, valued at approximately $16,872,153.06. This trade represents a 21.55% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 120,066 shares of company stock valued at $27,953,242. 0.31% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

LRCX has been the subject of a number of research analyst reports. TD Cowen lifted their price target on shares of Lam Research from $290.00 to $340.00 and gave the stock a “buy” rating in a research note on Thursday, April 23rd. Evercore lifted their price target on shares of Lam Research from $275.00 to $300.00 and gave the stock an “outperform” rating in a research note on Thursday, April 23rd. HSBC lifted their price target on shares of Lam Research from $221.00 to $247.00 and gave the stock a “hold” rating in a research note on Friday, April 24th. Wells Fargo & Company lifted their price objective on shares of Lam Research from $290.00 to $320.00 and gave the stock an “overweight” rating in a report on Thursday, April 23rd. Finally, Citic Securities lifted their price objective on shares of Lam Research from $165.00 to $275.00 and gave the stock a “buy” rating in a report on Friday, January 30th. Twenty-six analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $285.94.

Lam Research Stock Performance

Lam Research stock opened at $294.05 on Friday. The company has a market cap of $367.73 billion, a PE ratio of 55.48, a P/E/G ratio of 2.43 and a beta of 1.81. The company has a fifty day moving average price of $238.93 and a two-hundred day moving average price of $204.97. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.54 and a quick ratio of 1.77. Lam Research Corporation has a 12 month low of $74.65 and a 12 month high of $297.99.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings data on Wednesday, April 22nd. The semiconductor company reported $1.47 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.11. The firm had revenue of $5.84 billion during the quarter, compared to the consensus estimate of $5.70 billion. Lam Research had a net margin of 30.94% and a return on equity of 66.21%. The firm’s revenue was up 23.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.04 earnings per share. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Research analysts expect that Lam Research Corporation will post 5.67 earnings per share for the current year.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: B. Riley raised its price target on Lam Research to $350 from $330 and kept a Buy rating, citing strong earnings and solid execution. Why Analysts Are Growing More Confident In Lam Research (LRCX)
• Positive Sentiment: Erste Group Bank lifted FY2027 EPS estimates for Lam Research to $7.88 from $7.74, suggesting analysts see better long-term earnings power. Lam Research stock page
• Positive Sentiment: Recent coverage highlights Lam Research as an AI-fab beneficiary with orders beating expectations, supporting the case for further upside after a sharp rally. Lam Research (LRCX) Is Up 19.5% After AI-Fab Orders Beat Expectations Has The Bull Case Changed?
• Neutral Sentiment: Some commentary notes the stock has already surged dramatically over the past year, which may raise overbought concerns even as Wall Street remains constructive. Lam Research Has Surged 300% in a Year. Wall Street Sees More Gains Still Ahead
• Neutral Sentiment: Investor articles argue the rally may still have room to run, but that view is speculative rather than a direct fundamental update. Why Lam Research Still Looks Like a Buy After a 300% Rally

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.